Vaccine Fund - Finance
Recognizing the need to stop pneumococcal disease the Global Alliance for Vaccines and Immunization GAVI and the Vaccine Finance Fund established PneumoADIP at Johns Hopkins Bloomberg School of Public Health.
PneumoADIP's mission is to improve child survival and health by accelerating the evaluation and finance availability of and access to new life saving pneumococcal vaccines for the world's children.
GAVI is an historic alliance committed to improving child health. The Vaccine Fund is GAVI’s funding finance arm.
This program supports research and other activities to increase knowledge about pneumococcal diseases and their prevention by vaccination.
According to WHO pneumococcal pneumonia and meningitis are responsible for 800,000 to 1 million child deaths each year. That's the equivalent of at least one child dying every minute somewhere in the world of pneumococcal disease. With the financial strength in the world economy, is this necessary?